Skip to main content
Genetics logoLink to Genetics
. 2026 Aug 21;234(2):iyag221. doi: 10.1093/genetics/iyag221

Impact of naturally occurring target-site polymorphisms on an autonomous Cas9/guide RNA-based gene drive system for population modification of Anopheles gambiae s.l.

Rebeca Carballar-Lejarazú 1,#, Brian McNeely 2,#, Yuemei Dong 3, Thai Binh Pham 4, Taylor Tushar 5, Isaac Owusu-Frimpong 6, George Dimopoulos 7, Anthony A James 8,9,✉,3
Editor: M Wolfner
PMCID: PMC13643801  PMID: 42625514

Abstract

Malaria remains a significant global health challenge with an estimated 282 million cases reported in 2024. CRISPR/Cas9-based gene-drive systems have emerged as promising tools to block Plasmodium transmission by mosquito vectors. The TP13 drive system targets the Anopheles gambiae cardinal (Agcd) gene and carries 2 engineered monoclonal antibodies to achieve rapid population modification to prevent parasite transmission. Previous cage trials demonstrated complete drive introduction in 3 to 6 generations and supported modeling predicting a potential >90% reduction in malaria incidence under optimal conditions. However, naturally-occurring genetic polymorphisms in wild mosquito populations, particularly single-nucleotide polymorphisms (SNPs) within Cas9/guide RNA target sites, pose a potential barrier to drive efficiency. High genetic diversity in An. gambiae results in drive-system target-site variants, including an A→T transversion in the Agcd gene, which occurs at high frequencies in African populations and could affect TP13 drive dynamics. The impact of this and other SNPs on TP13 performance were assessed by establishing 3 An. gambiae Ndokayo lines, 1 with the wild-type Agcd and 2 with homozygous SNP haplotypes. We evaluated drive conversion rates in vivo, population dynamics in cage trials, fitness costs, and parasite suppression efficacy. No negative effects on drive performance and parasite suppression were observed. The results provide insights into the influence of naturally-occurring polymorphisms on gene drive propagation, informing safety, efficacy, and target product profile requirements for advancing gene-drive mosquitoes toward field trials.

Keywords: target site, mosquito, HDR efficacy, CRISPR, SNPs

Graphical Abstract

Graphical Abstract.

Map of Africa showing sources of Anopheles gambiae strains and a table of haplotype sequences.

Introduction

Malaria continues to be a major problem for many nations around the world. The World Health Organization (WHO) estimates that ∼282 million cases of malaria occurred in 2024 worldwide and has called for new tools to manage growing drug resistance in parasites and insecticide resistance in vector mosquitoes (World Health Organization 2025). To address the latter issue, recent work has highlighted the effectiveness of CRISPR/Cas9-based gene-drive systems in suppressing Plasmodium parasite development in mosquito vectors as part of a population modification approach (Gantz et al. 2015; Carballar-Lejarazú et al. 2020, 2023). The TP13 drive system, which links 2 engineered single-chain variable fragment monoclonal antibodies (scFvs; m1C3 and m2A10) to an autonomous drive component, AgNosCd-1, facilitates the rapid spread of anti-parasite effector transgenes in caged populations of wild-type mosquitoes and shows promise as a potential tool to reduce malaria transmission (Isaacs et al. 2011, 2012; Carballar-Lejarazú et al. 2023). This drive system targets the Anopheles gambiae cardinal gene (Agcd) at the same 23-nucleotide genomic sequence reported previously for AgNosCd-1 (Carballar-Lejarazú et al. 2020). Cage trials with 1:1 release ratios of homozygous AgTP13 gene drive to wild-type male mosquitoes show that drive constructs can be fully introduced into mosquito populations in as few as 3 generations (Carballar-Lejarazú et al. 2023). Furthermore, modeling these releases predicts that they could lead to a reduction of malaria incidence by over 90% within 3 mo under optimal conditions (Carballar-Lejarazú et al. 2023). If current trends continue, genetics-based technologies exploiting gene-drive systems may prove to be cost-effective and powerful tools for malaria control.

Drive systems such as TP13 must meet rigorous safety and efficacy standards in order to continue their development and begin field testing. Currently, gene drive technologies have been restricted to Phase 1 laboratory-based testing as outlined in the WHO guidance framework (World Health Organization 2021). Specific “go/no-go” criteria must be met for candidate mosquito strains to be eligible for Phase 2, which involves field research. Such criteria are defined explicitly in a target product profile (TPP) that describes minimally essential requirements for features such as transgene stability and fitness costs of drive constructs (Carballar-Lejarazú and James 2017). One criterion is the maintenance of drive efficiency in the presence of target-site variations in wild mosquito populations. These variations can manifest as single-nucleotide polymorphisms (SNPs) or insertions and deletions (indels) in regions of DNA targeted by the Cas9/guide RNA (gRNA) complexes. As currently drafted, the TPP specifies that the minimally essential requirement for target-site variations is to have no significant impact on drive dynamics and effector molecule efficacy (Carballar-Lejarazú and James 2017).

The target mosquito population in an ideal scenario would either have no variations at the target site, or the existing variations would have minimal impact on Cas9 cleavage and subsequent homology-directed repair (HDR). It is unlikely that the first condition can be met since the An. gambiae genome is highly polymorphic, with a nucleotide diversity (π) estimated to be between 0.98% and 1.02% in protein-encoding genes (Schmidt et al. 2020). This variation is higher than what is observed in other Dipterans such as Drosophila, where it ranges from 0.4% to 0.84% averaged over the nucleotide diversity of its 3 chromosomes in diverse populations (Lack et al. 2016). As a result of this high diversity, it has been estimated that 95% of possible Cas9/gRNA target sites in transcribed genes have polymorphisms in samples of the An. gambiae complex collected throughout Africa (Anopheles gambiae 1000 Genomes Consortium 2017; Schmidt et al. 2020). Since these variations occur naturally in wild mosquito populations, it is critical that any existing polymorphisms in gene-drive target sites be analyzed for their effect on Cas9/gRNA-mediated cleavage and gene-drive dynamics before any system is transitioned to the field.

The tolerance of each drive system to naturally-occurring variation may be different depending on the type of polymorphism found in the target-site sequence. Studies using cultured human cells have shown that Cas9 cleavage is affected strongly by the position and sequence of target-site/gRNA mismatches (Hsu et al. 2013; Kim et al. 2020). In general, gRNA target sites with polymorphisms located more distal to the protospacer adjacent motif (PAM) are more readily cleaved and have been shown to be more stable than those mismatches proximal to the PAM when initiating R-loop formation with Cas9/gRNA complexes (Wu et al. 2014; Rutkauskas et al. 2015). There also may be wide differences in mismatch sensitivity that are intrinsic to the gRNA sequence itself, with some being more sensitive to variant target sites and others readily able to direct cleavage at sites with mismatches (Fu et al. 2022). Furthermore, while SNPs surrounding the target site may not affect Cas9/gRNA recognition and cleavage, mismatches in sequence identity between the drive-system homology arms and DNA surrounding the target site can have major impacts on subsequent HDR as seen in the yellow fever mosquito, Aedes aegypti, and the southern house mosquito, Culex quinquefasciatus (Ang et al. 2022; Harvey-Samuel et al. 2026).

The complexity and abundance of factors that affect Cas9/gRNA recognition and cleavage make it difficult to predict the impact of a particular polymorphism outside the PAM site. Therefore, it is crucial that different target-site variations be tested on a case-by-case basis to ensure the effectiveness of a system in maintaining efficient gene drive propagation. Previous work has shown qualitative differences in the amount of cleavage in vitro for plasmids carrying different SNPs in the target site (Carballar-Lejarazú et al. 2020). However, it is important that these variants and haplotypes be studied in vivo in addition to in vitro cleavage analyses for their impact on repair outcomes. The work here examines the efficacy of a drive system, AgTP13, when present in the genetic background of strains containing naturally-occurring target-site SNPs. Assessments include drive conversion rates in vivo, population-level drive dynamics in small cage trials, fitness assays of transgenic and nontransgenic mosquitoes, and parasite challenge assays. The scope of the work done here is crucial for advancing this technology to Phase 2 trials (World Health Organization 2021).

Materials and methods

Mosquito lines and maintenance

Seven mosquito lines were utilized for these experiments, with 3 lines derived from an An. gambiae Ndokayo strain (referred to as AgNdo), 1 transgenic line, AgTP13, derived from the An. gambiae X1 line (a derivative of the G3 strain, Malaria Research and Reference Reagent Resource Center [MR4] strain MRA-112, BEI Resources), 2 lines (hemi- and homozygous) produced from hybridizations of an AgNdo line with the AgTP13 line, and the AgcdΔ11 line derived from the G3 strain that contains an 11-nucleotide deletion within the cardinal target site (strain MRA-1278, MR4, Volohonsky et al. 2015; Carballar-Lejarazú et al. 2022, 2023; BEI Resources 2024). The TP13 drive system has 2 engineered anti-Plasmodium falciparum effector genes, m1C3 and m2A10, encoding single-chain antibodies (scFvs) that target the ookinete and sporozoites stages, respectively, of the P. falciparum life cycle, regulated, respectively, by the bloodmeal-inducible, tissue-specific control DNA of the An. gambiae Carboxypeptidase A (AgCPA, [Cp]) and An. stephensi Vitellogenin 1 (AsVg1, [Vg]) genes (Isaacs et al. 2011, 2012; Carballar-Lejarazú et al. 2023). An An. gambiae strain from Burkina Faso was used in the survey of SNP variants in geographically diverse colonies.

The 3 AgNdo-derived lines include 1 line, AgNdo-WT, homozygous for a wild-type cardinal target site identical to the one targeted by the AgTP13 gRNA, 1 line, AgNdo-H1, homozygous for a haplotype containing an A→T transversion within the target site (2R:38748898) along with 3 additional SNPs (G→A at 2R:38748902, G→A at 2R:38748910, and C→T at 2R:38748916) distal to the 3′-end of the target site and another line, AgNdo-H2, homozygous for the 2R:38748898 transversion along with an additional SNP (A→C at 2R:38748865) 14 base pairs (bp) from the 5′-end of the target site (Fig. 1). The AgTP13 line is homozygous for a Cas9/gRNA drive system targeting the cardinal gene (gRNA Sequence: 5′-GGTTAGCGACGATGCCAAGGCGG-3′), a cyan fluorescent protein (CFP) dominant marker gene and the m1C3 and m2A10 scFvs.

Fig. 1.

For image description, please refer to the figure legend and surrounding text.

Agcd gRNA target-site variation. a) Origins of diverse An. gambiae strains with SNPs in the target-site sequences. b) Frequency of the 2R:38748898 A→T target-site SNP in An. gambiae samples from Africa. Anopheles gambiae samples originating from “Odeda,” “Lom-et-Djerem,” and “Busia” were analyzed from publicly available releases of whole genome sequences from the An. gambiae genomic surveillance project, releases 3.7 and 3.8 (Ag1000G Consortium 2023). Anopheles gambiae samples originating from “Valleé de Kou,” “Ndokayo,” and “STP Ana” were analyzed from Sanger sequencing data of lab-colonized strains from these regions. c) The cardinal gene target-site sequences (3′-5′; orientation) for the homozygous An. gambiae Ndokayo lines and reference (Ref; AGAP003502, An. gambiae PEST [AgamP4]; https://vectorbase.org/). The PAM site is shown in purple, target site is shown in blue, haplotype 1 (H1) SNPs are shown in green and haplotype 2 (H2) SNPs are shown in red. d) Cas9 in vitro cleavage assay for plasmids pBM1 to pBM5. Results are shown for the 5 plasmids containing different An. gambiae cardinal target sites. Linearized plasmids not cut by Cas9 are shown by the blue arrow. Linearized plasmids cut by Cas9 are labeled as cut fragment #1 (2,097 bp) and cut fragment #2 (981 bp) shown with red arrows. Map adapted from the National Geographic Society MapMaker (2025).

Generation of AgNdo-WT, AgNdo-H1, and AgNdo-H2 isolines

The AgNdo-WT, AgNdo-H1, and AgNdo-H2 lines were derived from a colony of the AgNdo mosquitoes, a mixed-allele strain carrying various frequencies of the wild-type, haplotype 1, and haplotype 2 alleles. At the time the AgNdo colony was used to generate the isolines, the frequency of alleles was 57.4% wild-type with 14.7% haplotype 1 and 27.9% haplotype 2 (n = 68) (Supplementary Table 1). Homozygous isolines were produced using family pools created by crossing 1 AgNdo male with ∼10 AgNdo females in a 16-oz (∼473 mL) cup. The families were allowed to mate for 3 to 4 d and assigned a number to keep track of the contributing male parent. After mating, males were removed from each family and sequenced individually to determine their genotype. Mated females from male parents homozygous for either the wild-type, haplotype 1, or haplotype 2 alleles were allowed to blood-feed for 2 consecutive days, and engorged females were added to a small cup to lay eggs. Ovipositing females were assigned a second number in addition to their male family number to track their contributing female parent. Females that laid eggs were subsequently sequenced to determine their genotypes. Any progeny that had 2 parents homozygous for the same allele were reared from larvae to adulthood, and ≥50 F1 mosquitoes were sequenced to verify that they were homozygous for the same target-site sequence as their male and female parents. This protocol was repeated on 2 separate occasions for the AgNdo-H1 line, with the first pooled mating generating 2 separate isofamilies that were homozygous for haplotype 1. These 2 isofamilies were subsequently combined, but sequencing of their progeny revealed that the combined families had some haplotype 2 alleles. The mating protocol was performed once more to produce the final homozygous haplotype 1 isofamily. The mating protocol for the AgNdo-H2 line was repeated multiple times to generate a homozygous line. The first pooled mating generated an isofamily that was heterozygous for haplotype 1 and haplotype 2. This isofamily mating protocol was repeated and produced 5 isofamilies that were homozygous for haplotype 2. These 5 isofamilies were combined to create a haplotype 2 line. However, sequencing of the progeny revealed some haplotype 1 alleles. Therefore, the mating protocol was repeated a third time to produce an isofamily homozygous for haplotype 2. Lastly, the mating protocol was performed only once for the AgNdo-WT line, with 1 isofamily being generated that was homozygous for the wild-type target site. All progeny from this isofamily were verified as homozygous wild-type by sequencing the target site.

Molecular analysis of individual mosquitoes

Genomic DNA from the various lines was extracted and the target site amplified using the Extract-N-Amp Tissue PCR Kit (Sigma-Aldrich, USA) and the primer pair Ak5/Ak21 to yield a predicted product amplicon 526 bp in length (Supplementary Table 2; Carballar-Lejarazú et al. 2023). The amplified DNA was resolved in a 1% agarose gel, and the DNA was extracted from excised samples recovered using the DNA Clean & Concentrator kit (Zymo Research, USA). Cleaned DNA was sent to Azenta for Sanger sequencing. The DNA sequence of each sample was compared to a reference sequence (AGAP003502, An. gambiae PEST [AgamP4]; https://vectorbase.org/) using Snapgene bioinformatics software. Genotypes of each sample were determined by observing the chromatogram data that displays a different color for each unique nucleotide. DNA samples from mosquitoes containing the drive construct were validated using the same process with the primer pair Ak5/TP217, which amplify the drive allele with a predicted product amplicon 1,021 bp in length (Supplementary Table 2; Carballar-Lejarazú et al 2023).

SNP frequency analysis of wild An. gambiae field samples and recently colonized laboratory strains

DNA sequence data from wild An. gambiae samples were accessed using the MalariaGen Ag3 cloud data via Google Cloud. Precise information on the cardinal SNP frequency, 2R:38748898, in wild An. gambiae was obtained using the “snp_allele_freqs_df=ag3.snp_allele_frequencies(transcript=, cohorts=, drop_invariant=, and sample_sets=)” function, specifying SNP frequencies in transcript: “AGAP003502-RA,” cohorts: “admin2_year,” drop_invariant: “false,” and sample_sets: “1315-VO-NG-OMITOLA-OMOL-NG-2008, 1288-VO-UG-DONNELLY-VMF00219, and 1281-VO-CM-CHRISTOPHE-VMF00208.” The cohort: admin2_year parameter groups samples based on region, collection year, and taxon. The sample sets: “1315-VO-NG-OMITOLA-OMOL-NG-2008,” “1288-VO-UG-DONNELLY-VMF00219,” and “1281-VO-CM-CHRISTOPHE-VMF00208” parameters contain An. gambiae sequence data from Nigeria, Uganda, and Cameroon, respectively. The data frame was organized to display only the SNP frequency by using the function: “frequency_columns = [col for col in snp_allele_freqs_df.columns if col.startswith(“frq_”)].” The data frame then was generated to display SNP frequency only at the desired position within the cardinal target site by using the function “snp_allele_freqs_df.loc[(“2R”, 38_748_898), frequency_columns].”

The 2R:38748898 cardinal SNP frequency data for each year and region were displayed on a data frame and compared to the overall sample metadata that displays detailed information on the total number of samples collected in each year and the exact collection spot for each sample set. The sample metadata were displayed using the function ag3.sample_metadata(sample_sets=“ ”) with sample sets: “3.8” for 1315-VO-NG-OMITOLA-OMOL-NG-2008 and 1288-VO-UG-DONNELLY-VMF00219 and sample sets: “3.7” for 1281-VO-CM-CHRISTOPHE-VMF00208. A weighted average SNP frequency for a specified time period was calculated as follows: (i) a weighted yearly SNP frequency was calculated for each location by the following equation (yearly SNP frequency) × (the number of samples from that year/the total number of samples from every year included in analysis) and (ii) the weighted SNP frequency for each year was summed and divided by the number of input values to generate a weighted average SNP frequency. The SNP frequencies in the recently-colonized laboratory strains were determined using the same Sanger sequencing protocol described above with the allele type data of >50 mosquitoes from the first-generation cohorts received by the James laboratory. These mosquitoes included the An. gambiae Ndokayo strain received from (MR4, BEI Resources) and colonized from “Ndokayo” Cameroon (2008), the An. gambiae Burkina Faso strain received from Dr. Abdoulaye Diabaté (Professor Roch K. Dabire and the Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l’Ouest) and colonized from “Valleé de Kou” Burkina Faso (2021), and the An. coluzzii STP Ana strain received from the UC Malaria Initiative and colonized from São Tomé and Príncipe (2023).

Cas9 in vitro cleavage assay

A total of 5 plasmids with different target-site sequences were created for use in the in vitro cleavage assay involving Streptococcus pyogenes Cas9 endonuclease (Supplementary Table 3). These plasmids were generated using amplified sequences from the AgNdo-WT, AgNdo-H1, AgNdo-H2, and AgcdΔ11 lines, all of which include the cardinal target site plus a 36-bp flanking sequence adjacent to the 5′-end from the target site and a 329-bp flanking sequence at the 3′-end of the target site. The AgcdΔ11 line target site serves as a cleavage-negative control (Carballar-Lejarazú et al. 2022). Insert sequences used for all plasmids were extracted from mosquito samples using Extract-N-Amp Tissue PCR Kit (Sigma-Aldrich). All insert fragments were amplified using CloneAmp HiFi PCR premix (Takara Bio). The insert sequence for plasmids pBM1 to pBM4 were amplified as 1 fragment using the CloneAmp HiFi PCR premix (Takara Bio), with primer pair BM1/BM2 (Supplementary Table 2). The pBM5 insert sequence was amplified as 2 fragments using DNA from a AgNdo-WT mosquito sample. The first fragment includes the 94-bp 5′-end upstream flanking sequence and the target site with no PAM amplified with primer pair BM4/BM2. The second fragment (368 bp), amplified with primer pair BM1/BM3, also contains the target site with no PAM along with the 3′-end downstream flanking sequence. This fragment also was amplified using the CloneAmp HiFi PCR premix (Takara Bio), forward primer BM1, and reverse primer BM3 (368 bp). Amplified inserts were resolved in 1% agarose gels and cleaned using the Zymo Gel DNA Recovery Kit. Following the amplification and isolation of the inserts, all fragments were cloned into linearized pUC19 vectors via the In-Fusion cloning method (Takara Bio) at a molar ratio of 3:1 insert-to-vector for pBM1 to pBM4 or 3:3:1 inserts-to-vector for pBM5. Successfully transformed plasmids were extracted and cleaned using QIAprep Spin Miniprep Kit (QIAGEN) and verified via Sanger sequencing by Azenta. A total of 1.5 μg of each plasmid was treated with the ScaI-HF restriction enzyme (New England BioLabs) for 15 min at 37 °C to linearize them. The plasmids then were mixed with preincubated Cas9 (New England BioLabs) and wild-type cardinal gRNA (Synthego) at a molar ratio of 10:10:1 Cas9–gRNA–plasmid. This mix was incubated at 37 °C for 15 min and then for 10 min at room temperature after the addition of 1 μL proteinase K. A 2% agarose gel was utilized to resolve the reaction products for subsequent analysis.

AgTP13 introgression into AgNdo-WT, AgNdo-H1, and AgNdo-H2 lines

A total of 3 mating experiments were utilized to test the TP13 introgression drive dynamics into the AgNdo-WT, AgNdo-H1, and AgNdo-H2 lines. Three replicates each of 75 AgTP13 males crossed to 75 females from either AgNdo-WT, AgNdo-H1, or AgNdo-H2 represent the parental generation of each experiment as described in Tushar et al. (2024). All resulting F1 progeny from the parental cross were hatched in plastic containers (11″ [7.94 cm] × 6″ [15.24 cm] × 4″ [10.16 cm]) with ∼175 larvae per container. If >1,000 progeny were generated from the parents, an equal proportion of randomly-selected second instar (L2) larvae were taken from each container and consolidated in 5 new containers that contained 175 larvae each. The larvae from 4 of these containers were reared and a representative sample of ∼600 pupae resulting from them screened for phenotypes. Mosquitoes from the fifth container were screened as pupae, reared to adults, and allowed to mate freely and contribute to the next generation. If <1,000 larvae were hatched from the parents, then the total population was screened with 1 container created containing the 175 randomly selected L2 larvae that contributed to the next generation. The pupae were screened based on 3 parameters: sex, presence/absence of a dominant CFP marker, and eye phenotype (black-eye [wild-type], red-eye [cardinal], or tear [mosaic]). All F1 mosquitoes that had the ability to contribute to the next generation, along with an additional sample of ∼50 F1 mosquitoes from each unique eye phenotype, were frozen to preserve for future sequencing. A total of 20 to 30 F1 individuals (or all if less than 20 produced) with the black-eye/CFP+ phenotype per experiment and replicate were sequenced in the F1 generation. This same procedure was repeated for the F2 generation, where a minimum of 600 randomly selected pupae were screened and sorted and a subset (20 to 30 mosquitoes per phenotype, experiment, and replicate, or all if less than 20 produced) of the following phenotypes sequenced: black-eye/CFP+, black-eye/CFP−, red-eye/CFP+.

Introduction of the TP13 gene-drive system into AgNdo-H2

A TP13/Ndokayo hybrid line, designated AgNdoH2-TP13, was created by crossing males from the homozygous AgTP13 line with females from the homozygous AgNdo-H2 line. The black-eye/CFP+ hemizygous progeny with 1 copy of an AgTP13 allele and 1 copy of an AgNdo-H2 allele were maintained as a hemizygous line by continuously backcrossing black-eye/CFP+ drive hemizygous males with AgNdo-H2 females. The hemizygous line also was converted into a homozygous line by allowing AgNdoH2-TP13 hemizygous males to backcross with AgNdo-H2 females for 5 generations, followed by an intercross of the fifth generation of AgNdoH2-TP13 hemizygous individuals in which subsequent progeny displaying a drive homozygous phenotype (red-eye/CFP+) were selected and allowed to continuously intercross.

AgNdoH2-TP13 hemizygous male and female gene drive dynamics

AgNdoH2-TP13 drive efficiency was compared between males and females through 2 different sets of hemizygous outcrosses to AgNdo-H2 for 2 generations. For male drive dynamic experiments, 3 replicates of 50 AgNdoH2-TP13 hemizygous male parents (black-eye/CFP+) with 1 copy of the drive system and 1 copy of the haplotype 2 allele were crossed to 50 AgNdo-H2 female parents (black-eye/CFP−) to establish the F1 generation. For female drive dynamic experiments, the parents included 3 replicates of 50 AgNdoH2-TP13 hemizygous female parents (black-eye/CFP+) with 1 copy of the drive system and 1 copy of the haplotype 2 allele crossed to 50 AgNdo-H2 male parents (black-eye/CFP−) to establish the F1 generation. F1 mosquitoes from male and female lineages were screened at the pupal stage based on eye phenotype (black-eye, red-eye or tear) and presence or absence of the CFP marker. A random sample of 50 male and female progeny from each lineage displaying a hemizygous phenotype (black-eye/CFP+) were separated from the F1 generation after screening as pupae, reared to adults as virgins, and outcrossed once more to 50 AgNdo-H2 from the opposite sex. F2 progeny from these crosses were screened in the same manner as the F1 generation. F1 and F2 progeny of each phenotype and a subset of 20 to 30 wild-type individuals (or all if less than 20 produced) from every male and female lineage replicate were preserved for DNA sequencing. The experiments described above were performed at 2 different time points, once with the hemizygous line prior to initiating the cage trials as described below and a second time when a sample of mosquitoes was taken from the population of each replicate of the cage trial after 18 continuous generations (∼1 yr).

AgNdoH2-TP13 cage trials

Triplicate experimental cages, A, B, and C, each with a volume of 5,000 cm3, were established with a 1:1 initial release ratio of 75 homozygous drive males AgNdoH2-TP13 to 75 wild-type AgNdo-H2 males. A total of 150 AgNdo-H2 females were added to each cage to achieve a balanced male-to-female ratio with a total population of 300 adults per cage. Subsequent generations were screened and analyzed following the methodology described by Carballar-Lejarazú et al. (2023). Every generation, 300 randomly-selected L2 larvae from each cage were removed to a new cage for the subsequent generations, and an additional 800 randomly-selected L2 larvae were reared separately to pupae for sexing and phenotypic screening. Pupae were screened for the CFP marker to determine the presence or absence of the drive system and for eye color phenotype (wild-type black-eye, cardinal mutant red-eye, or mosaic tear-eye). The remaining larvae were counted and added to determine the total population size.

Molecular validation of gene-drive cassette integration and effector molecule integrity in AgNdoH2-TP13 cage trials

Genomic integration was verified by gene amplification analyses using genomic DNA of cage trial samples at selected generations as templates and gene-specific oligonucleotide primers. Genomic DNA extraction, PCR reactions and sequencing were carried as described in Carballar-Lejarazú et al. (2023). The right-hand junction between the TP13 drive cargo and the cardinal gene left homology arm was verified by the primer pair VgProm-seqF4/TP179 (Supplementary Table 2). Primers upHm1cdn/TP179 were used to amplify a fragment of the Agcd gene spanning the insertion location of the drive cassette between the left and right homology arms to verify the presence of a WT allele in the hemizygous mosquitoes. The primer pair upHM1cdn/TP217 was used for the left-hand junction between the right homology arm and the cargo of TP13. The integrity of the effector molecules was validated using primer pairs TP218/TP219 and Vg3UTR-seqF2/TP220 to amplify fragments from the 5′-end untranslated region (UTR) to the 3′-end UTR of m1C3 and m2A10, respectively.

RT-PCR validation of antimalarial effector and Cas9 gene expression

Females from each cage trial at selective generations were bloodfed and collected after 24 h for RT-PCR analysis of antimalarial effector gene transcripts and abundance and Cas9 expression. Total RNA extractions, cDNA synthesis, and PCR reactions were carried out as described in Carballar-Lejarazú et al. (2023). Synthesized cDNA was amplified with gene-specific primer pairs, TP236/TP237, TP240/TP241, and RPS7/RPS7-R, to determine the expression of m1C3, m2A10, and the ribosomal protein, RPS7, respectively.

AgNdo fitness experiments

Life-table parameters for AgNdo, AgNdo-H2, and AgNdoH2-TP13 hemizygous and homozygous lines were evaluated following the methodology described previously for An. gambiae and An. coluzzii gene drive lines (Carballar-Lejarazú et al. 2020, 2023). All assays were conducted in biological triplicates except for the longevity experiments where survival curves were based on 100 males and 100 females per line. Data from hemi- and homozygous AgNdoH2-TP13 and AgNdo were compared with the triplicate biological replicate AgNdo-H2 data. The combined data from all 3 replicates of each line were used in the analyses. All statistical tests were conducted in R (version 4.2.2) using the same analytical methods as reported in Carballar-Lejarazú et al. (2023).

Male likelihood experiments and molecular analysis

The ability of haplotype-bearing and gene drive-carrying males to mate with females and contribute to the next generation in the presence of competing males with other genotypes is important for drive dynamics. Male progeny from outcrosses of the AgNdoH2-TP13 line to the AgNdo-H2 line, male progeny from AgNdoH2-TP13 intercrosses, and males from the AgNdo colony were tested in competition with AgNdo-H2 males. A total of 150 3- to 5-d-old virgin AgNdo-H2 females were mated with 75 3- to 5-d-old virgin test males (outcross or intercross AgNdoH2-TP13 or AgNdo) and 75 AgNdo-H2 control virgin males with all males from each respective line and strain age-matched to the day in each replicate. Mating took place in triplicate 5,000-cm3 cages over the course of 3 d, and females then were provided with blood meals on 2 successive days. After feeding, females were allowed 2 d to complete the gonotrophic cycle and then provided an egg cup for oviposition for 3 d. All eggs and larvae were subsequently hatched from the egg cup and reared under standard insectary conditions. A minimum of 1,000 randomly selected larvae were screened per replicate for presence/absence of the dominant fluorescent marker at the L3-L4 stage, and the total number of positive and negative mosquitoes was recorded.

The haplotype 2 SNP frequency in the AgNdo strain at the time of the competitive crosses was determined with PCR and Sanger sequencing using a total of 153 individual siblings of the males used in the male-likelihood experiment. For each replicate of the AgNdo and AgNdo-H2 male likelihood experiment, 25 pools of 50 L4 larvae progeny were extracted for genomic DNA (gDNA) using the Blood and Tissue DNeasy kit (QIAGEN). The gDNA from each pool was normalized to 100 ng/μL and used as template for PCR amplification with the primer pair TP624 and TP635 (Supplementary Table 2) and CloneAmp Hifi PCR Mix (Takara Bio) following the manufacturer’s instructions to produce a fragment 271 bp in length spanning the cardinal gRNA target site. The amplicons were subjected to deep sequencing with Amplicon-EZ service from Genewiz (Azenta). Deep sequencing data were analyzed with CRISPResso2 (Clement et al. 2019) for haplotype 2 SNP frequency in the progeny resulting from the crosses.

Parasite challenge assays

Adult hemi- and homozygous AgNdoH2-TP13 and AgTP13 adult females were used in parasite membrane feeding assays along with their respective AgNdo-WT and AgX1 control lines. All mosquitoes were maintained under standard insectary conditions as described (Carballar-Lejarazú et al. 2023). Briefly, mosquitoes were kept at 27 ± 1 °C, 70% to 80% relative humidity, with a 12:12-h light:dark photoperiod. Females were provided a 10% sucrose solution ad libitum until just prior to the infectious blood meal. The P. falciparum NF54 strain was maintained in human O+ erythrocytes until mature stage V gametocytes were obtained. Cultures were diluted to achieve target gametocytemia levels for experimental challenges and designated “low” (0.08%) gametocytemia, representative of many natural transmission levels, and “medium” (0.1%), and “high” (0.3%) gametocytemia levels, used to increase statistical power in laboratory assays. Infectious blood meals were prepared by combining cultured gametocytes with fresh human serum and erythrocytes. Blood meals were maintained at 37 °C and offered to mosquitoes for 60 min using a membrane-feeding apparatus fitted with parafilm following previously established protocols (Tripathi et al. 2020). Fully engorged females were separated within 1-h post-feeding and maintained on 10% sucrose for the duration of the parasite development period. Additional uninfected blood meals were provided at 5- and 10-d post-infection to boost the blood meal-inducible effector gene expression.

Oocyst counts (intensities of infection) were obtained from midguts dissected at 7 to 8 d post-infection, stained with 0.1% mercurochrome, and examined under a light microscope at 100× or 200× magnification. The number of oocysts per midgut was recorded for each mosquito. Sporozoite counts were obtained from salivary glands dissected 14 to 16 d post-infection. Salivary glands were homogenized in 30 µL of phosphate-buffered saline (PBS), and 10 µL of the homogenate was loaded onto a hemocytometer for counting using light microscopy (Leica). Two fields were counted for the low-infection samples, and the average sporozoite number calculated from the largest grid (0.1 µL) was multiplied by 300. The high-infection samples were counted using the smallest grid (0.004 µL), or the next appropriate scale depending on the density, and multiplied accordingly.

Dot plots of parasite counts (oocysts and sporozoites) were generated in GraphPad Prism version 10. Mean and median intensities of infection were calculated for each group. Prevalence (percentage of infected mosquitoes) and intensity data from independent biological replicates were pooled prior to analysis to maintain balanced sample sizes across treatments. Infection intensity was compared between experimental and control groups using the 2-tailed Mann–Whitney U test. Prevalence was compared using Fisher's exact test. Differences were considered statistically significant at P < 0.05.

Ethics statement

All studies were performed in compliance with the requirements of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, and the Institutional Animal Care and Use Committee at Johns Hopkins University approved the protocol (permit no.: M006H300). Mice were used only as a blood source for mosquito rearing. Commercial anonymous human blood was used for Plasmodium gametocyte cultures and infection assays and informed consent was not required.

Statistics

P-values <0.05 were considered significant in all tests.

Results

Generation of An. gambiae Ndokayo wild-type and SNP haplotype target-site isolines

Twelve of the 23 nucleotides in the Agcd target-site DNA sequence used in the TP13 and AgNosCd-1 drive systems have naturally-occurring SNP variations, and these are relatively uncommon (0.06% to 5.8%) except at 1 position (2R:38748898) distal to the PAM site (refer to Supplementary Table 18 in Carballar-Lejarazú et al. 2020). This position has an A→T transversion located 17 bp to the 5′-end of the PAM and is found in as high as 43% of the various wild A. gambiae s.l. populations surveyed by the 1,000-genome consortium and among recently colonized laboratory strains (Fig. 1a; Ag1000G Consortium 2023). Live colonies of variant-carrying strains are generally unavailable, but the Ndokayo strain (AgNdo) was obtained from a colony kept at the MR4 (strain MRA-1278, MR4, BEI Resources) and we obtained a colony from Burkina Faso (BF) as a gift of Dr. Abdoulaye Diabaté.

Preliminary molecular characterizations of the gene-drive target sites in these strains showed that the A→T SNP transversion (2R:38748898) was present in multiple haplotypes with variable frequencies in each strain (Fig. 1a). Haplotype 1 (H1) has the 2R:38748898 transversion along with 3 additional SNPs (G→A at 2R:38748902, G→A at 2R:38748910, and C→T at 2R:38748916) distal to the 3′-end of the target site and is represented in 13% of the alleles in the Ndokayo and BF strains (Fig. 1b; Table 1). Haplotype 2 (H2) represents 16% of the alleles seen in the Ndokayo strain and has the 2R:38748898 SNP along with an additional SNP (A→C at 2R:38748865) 14 bp from the 5′-end of the target site. Haplotype 3 (H3) represents 27% of the alleles found in the Burkina Faso strain and has the 2R:38748898 SNP along with a C→T transversion distal to the 3′-end of the target site. Continued long-term maintenance of the colonies in our laboratory resulted in apparent heterozygosity of haplotypes 2 and 3 with canonical wild-type alleles in their respective strains accompanied by the loss of haplotype 1, most likely as a result of founder effects eliminating the least frequent variant. We chose the Ndokayo strain for further analysis because it contained the greatest diversity of target-site haplotypes, and generating all experimental isolines from a single genetic background would minimize other, potentially confounding, genetic effects.

Table 1.

Target-site SNP frequency in the An. gambiae Agcd locus in Ndokayo and Burkina Faso strains.

Ndokayo Burkina Faso
Date (n)a WTb,c H1c H2c Date (n)a WTb,c H1c H3c
05/2021 (130) 0.71 (184/260) 0.13 (34/260) 0.16 (42/260) 02/2023 (54) 0.60 (65/108) 0.13 (14/108) 0.27 (29/108)
2022 (34) 0.57 (39/68) 0.43 (29/68) 07/2023 (60) 0.62 (75/120) 0.17 (20/120) 0.22 (26/120)
12/2024 (153) 0.51 (156/306) – 0.49 (150/306) 02/2024 (57) 0.68 (78/114) 0.06 (7/114) 0.25 (29/114)
– – – – 01/2025 (57) 0.50 (57/114) – 0.50 (57/114)

aDate and number of samples sequenced.

bWild-type canonical sequence.

cFrequency of total samples with genotype (number of alleles/total alleles).

Agcd, Anopheles gambiae cardinal gene; H, haplotype.

Single AgNdo males and females were used to generate 3 isolines to assess the impact of the high-frequency polymorphisms on the TP13 drive system. The 3 derived lines include 1 line, AgNdo-WT, homozygous for the wild-type cardinal target site identical to the one targeted by the AgTP13 gRNA and lines homozygous for haplotypes 1, AgNdo-H1, and 2, AgNdo-H2 (Fig. 1c).

Cleavage in vitro of AgNdo variant target sites

The Cas9/gRNA complex cleavage efficiency for the target-site mutations was determined using an in vitro cleavage assay and 5 plasmids containing the different target-site sequences. The 5 plasmids (pBM1 to pBM5) contained the AgNdo-WT, AgNdo-H1, AgNdo-H2, AgcdΔ11 (negative control), and AgNdo-WT-PAM deleted (negative control) target sites, respectively, along with a 36-bp homology arm adjacent to the 5′-end of the target site and a 329-bp homology arm adjacent the 3′-end (Supplementary Table 3; Carballar-Lejarazú et al. 2022). The plasmids were incubated with Cas9/wild-type gRNA complexes and cleavage observed by the presence of specific DNA fragments resolved in agarose gels. The results show that all plasmids with the natural SNPs, pBM1 to pBM3, were cleaved, while the negative controls, pBM4 and pBM5, remained uncut (Fig. 1d). There were no visible qualitative differences in the amounts of cleavage with plasmids containing either haplotype 1 or haplotype 2 (pBM2 or pBM3) in comparison with the wild-type sequence (pBM1) as evidenced by the similar staining intensities for the cut fragments in pBM1 to pBM3. However, in the absence of densitometry, these differences are not definitive. While these findings show that the AgTP13 Cas9/gRNA complex can efficiently cleave target sites containing haplotype 1 or haplotype 2 sequences in vitro, they do not reveal what impact the haplotypes may have on cleavage in vivo. It is possible that the haplotypes may impact post-cleavage HDR or other end-joining repair outcomes, or the abilities of the Cas9/gRNA complexes to cleave the target site in a time- and site-specific manner. Thus, we performed a number of experiments to assess them in vivo.

TP13 gene-drive system dynamics following outcrosses to Ndokayo isolines

Three different mating experiments utilizing 75 homozygous AgTP13 males crossed to 75 Ndokayo females from either the AgNdo-WT, AgNdo-H1, or AgNdo-H2 lines were performed in triplicate to determine the impact of haplotypes on the ability of TP13 to drive in the presence of target-site SNPs. Briefly, F1 progeny from these crosses were screened for eye phenotypes and to ensure the presence of the CFP marker, and 150 randomly-selected F1 progeny were subsequently allowed to intercross to produce an F2 generation (Table 2). Drive inheritance and drive conversion rates were determined in the F2 generation based on the proportions of progeny with (CFP+) or without (CFP−) the dominant marker gene and by determining the corresponding genotypes of each unique eye phenotype resulting from the F1 hemizygous intercrosses. Possible F2 generation eye phenotypes include black-eye/CFP+, red-eye/CFP+, tear eye/CFP+, black-eye/CFP−, and red-eye/CFP− (Carballar-Lejarazú et al. 2022, 2023; Tushar et al. 2024). The tear-eye phenotype was shown previously to result from maternal- and paternal-effect target-site cleavage in somatic tissues that generated mosaic genotypes of functional and nonfunctional mutant alleles in small clones of cells that produced mosquitoes with some but not all ommatidia lacking pigment (Carballar-Lejarazú et al. 2020, 2022, 2023). The expected genotypes possible from these phenotypes based on previous observations of the AgNosCd-1 and AgTP13 drive systems are black-eye/CFP+ mosquitoes with 1 copy of the TP13 drive allele and either 1 copy of a wild-type cardinal allele (cd+) or functional mutant allele; mosquitoes with a red-eye/CFP+ phenotype that have either 2 copies of the TP13 drive allele or 1 copy of the TP13 drive allele and a nonfunctional mutant allele (cd−); mosquitoes with a tear-eye/CFP+ phenotype having 1 copy of the TP13 drive and a mixture of wild-type and mutant alleles indicative of mosaicism at the cardinal gene; black-eye/CFP− mosquitoes either heteroallelic for a wild-type cardinal allele and functional mutant allele or homozygous for either allele, and mosquitoes with a red-eye/CFP− phenotype conferred by 1 (homozygous) or 2 (heteroallelic) nonfunctional mutant alleles.

Table 2.

Eye-phenotype frequencies of progeny from AgTP13-Ndokayo introduction crosses.

Parental crossa F1 Progenyb
Black-eye/CFP+ Tear-eye/CFP+ White-eye/CFP+
♂AgTP13 × ♀AgNdo-WT 99.6% (3,225/3,237) 0.4% (12/3,237) -
♂AgTP13 × ♀AgNdo-H1 99.8% (2,368/2,372) 0.2% (4/2,372) -
♂AgTP13 × ♀AgNdo-H2 99.22% (2,401/2,420) 0.74% (18/2,420) 0.04% (1/2,420)
F1 Hybrid IXc F2 Progenyb
Black-eye/CFP+ Red-eye/CFP+ Tear-eye/CFP+ Black-eye/CFP−
AgTP13/AgNdo-WT 15.1% (272/1,802) 84.2% (1,518/1,802) 0.2% (3/1,802) 0.5% (9/1,802)
AgTP13/AgNdo-H1 13.8% (258/1,867) 85.8% (1,602/1,867) - 0.4% (7/1,867)
AgTP13/AgNdo-H2 14.3% (274/1,918) 85.5% (1,640/1,918) 0.1% (2/1,918) 0.1% (2/1,918)

aCrosses of 75 homozygous AgTP13 ♂s to 75 ♀s from each homozygous Ndokayo line.

bCombined data from 3 replicates.

cIntercrossing of 150 randomly selected F1 mosquitoes from each parental cross.

As expected of outcomes of crossing homozygous TP13 male parents, all progeny in the F1 generation were confirmed to be phenotypically CFP+ in all 3 experiments (Table 2 and Supplementary Tables 4 to 6). The majority of progeny had the black-eye/CFP+ phenotype resulting from a wild-type cardinal allele and 1 drive allele (Supplementary Tables 1 and 7). However, there were small numbers of progeny in each experiment with the tear-eye/CFP+ phenotype, 0.4% (AgNdo-WT), 0.2% (AgNdo-H1), and 0.74% (AgNdo-H2) (Supplementary Tables 4 to 6). The tear-eye/CFP+ F1 individuals were not sequenced in these experiments due to their allelic complexity (Carballar-Lejarazú et al. 2025). There were no significant differences among all 3 parental crosses in the likelihood to produce tear-eye progeny (pairwise independent samples t-tests with Bonferroni correction, adjusted P-values ≥ 0.12). A single white-eye/CFP+ mosquito was observed in the AgNdo-H2 parental cross and sequencing of the known genes involved in eye pigmentation in this individual revealed that the phenotype resulted from an insertion of 667 bp in length into exon 4 of the An. gambiae white AGAP000553 gene (Supplementary Fig. 1, Supplementary Methods). This spontaneous white-eyed phenotype was observed on occasion in the AgNdo colony and is unrelated to the drive activity.

All 3 experiments showed high drive inheritance in F2 generation progeny from subsequent haplotype-specific intercrosses regardless of their target-site genotype (Table 2 and Supplementary Tables 4 to 6). Over 99% of F2 progeny had at least 1 copy of the TP13 drive, which is much higher than the 75% that would be expected to result from Mendelian random segregation (AgNdo-WT: χ2 = 576.91, P < 2.2−16; AgNdo-H1: χ2 = 603.81, P < 2.2−16; AgNdo-H2: χ2 = 634.01, P < 2.2−16). Most individuals (average of 85.2% across all 3 experiments) exhibited the red-eye/CFP+ phenotype indicative of either 2 copies of the drive allele or 1 copy of the drive allele and 1 copy of a nonfunctional mutant allele. Molecular analysis confirmed that every red-eye/CFP+ phenotype mosquito sequenced (n = 199) from all 3 replicates of every experiment had only TP13 drive alleles, and no nonfunctional mutant alleles were observed (Supplementary Tables 1 and 8). The second most common phenotype (averaging 14.4%) was black-eye/CFP+ individuals, which could have either an unaltered AgNdo-WT, AgNdo-H1, or AgNdo-H2 allele or functional mutant allele. The majority (>98% of the 206 sequenced) had unaltered AgNdo-WT, AgNdo-H1, or AgNdo-H2 alleles. However, there was evidence of functional mutant alleles in black-eye/CFP+ individuals sequenced from the AgNdo-WT (1.4%; 1/73) and AgNdo-H1 (1.5%; 1/67) intercrosses, while AgNdo-H2 intercrosses only produced black-eye/CFP+ individuals with AgNdo-H2 alleles (66/66) (Supplementary Tables 1, 8, and 9). Interestingly, no evidence of mutant alleles was observed in previous male lineage introduction crosses involving the AgNdo strain (containing a mix of haplotypes 1, 2, and wild-type target sites) and the AgNosCd-1 gene drive line (Tushar et al. 2024). The black-eye/CFP− individuals sequenced from the AgNdo-WT and AgNdo-H1 intercrosses also contained mutant alleles, 14.3% (1/7) and 28.6% (2/7), respectively. One mutant allele from the AgNdo-H1 intercross was shared with its black-eye/CFP− and black-eye/CFP+ siblings from the same replicate (Supplementary Table 9). These data are consistent with the early formation of this allele in the germline with subsequent clonal copies being passed along in multiple gametes to progeny (“clustering” effect; Carballar-Lejarazú et al. 2025). However, these data do not provide evidence for which sex the germline mutation event may have occurred since both hemizygous drive-carrying males and females contributed to the F2 generation.

Despite the small rates of formation of mutant alleles, haplotype 1 or haplotype 2 target sites did not have a significant effect on the drive dynamics of the TP13 drive system. One way this can be quantified is by calculating the drive conversion rate (“homing”) for each experiment, which measures the frequency of the number of target alleles converted to drive alleles divided by the total number of potential target alleles and expressed as a percentage (Sánchez et al. 2020; Carballar-Lejarazú et al. 2023, 2025). There is no significant difference between AgNdo-WT (83.7%), AgNdo-H1 (85.4%), and AgNdo-H2 (85.4%) when looking at the drive conversion rates of all 3 experiments (pairwise independent samples t-tests with Bonferroni correction, adjusted P-values ≥ 1.0; Supplementary Table 10). This supports the conclusion that Cas9/gRNA complexes are able to cleave target sites with the haplotype 1 and haplotype 2 SNPs as efficiently as canonical wild-type target sites.

AgNdoH2-TP13 male and female lineage gene-drive dynamics

The drive dynamics of the TP13 system in a population with a SNP background was determined by introgressing it into the AgNdo-H2 line by outcrossing homozygous AgTP13 males to AgNdo-H2 females. This was followed by backcrossing resulting AgTP13/AgNdo-H2 males to AgNdo-H2 females for an additional 4 generations to yield the AgNdoH2-TP13 gene drive line theoretically carrying ∼96.9% of the AgNdo-H2 genome except for the Y chromosome (discussed in Carballar-Lejarazú et al. 2025).

Sex-specific differences in the drive dynamics and mutant allele formation rates in the AgNdoH2-TP13 line were examined in outcrosses of hemizygous AgNdoH2-TP13 males or females containing 1 TP13 allele and 1 haplotype 2 allele to AgNdo-H2 mosquitoes of the opposite sex. The F1 progeny from these crosses were screened based on eye phenotypes and a sample of hemizygous black-eye/CFP+ male and female progeny were removed, kept as virgins, and outcrossed once more to AgNdo-H2 of the opposite sex to observe drive dynamics over 2 generations. For both male and female lineages, the majority of progeny generated from the hemizygous outcrosses had a black-eye/CFP+ phenotype in the F1 and F2 generations (Table 3). However, it was observed that F1 and F2 progeny from AgNdoH2-TP13 hemizygous males had a significantly higher average drive inheritance of 97.2% compared to female founder lineages, which averaged 80.7% (Table 3, Supplementary Tables 11 and 12) (χ2 = 758, P < 2.2−16). Previous outcrosses with hemizygous AgTP13 (X1 background) also have shown that hemizygous males have a higher drive inheritance although the difference is much less pronounced, ranging from 99.5% to 100% in hemizygous AgTP13 males to 85.5%to 96.9% in hemizygous AgTP13 females (Carballar-Lejarazú et al 2023).

Table 3.

Gene-drive inheritance in outcrosses of female and male lineage AgNdoH2-TP13 hemizygotes.

Generation Male-founder lineagea Female-founder lineagea
CFP+ progenyb
F1 ♂ 98.1%
(2,773/2,828)
♀ 88.2%
(4,039/4,581)
F2 ♂ 96.9%
(2,072/2,139)
♀ 77.7%
(1,661/2,137)
♂ 96.8%
(1,348/1,392)
♀ 75.3%
(1,059/1,406)
Red-eye progenyb
F1 ♂ 0%
(0/2,828)
♀ 0.02%
(1/4,581)
F2 ♂ 0%
(0/2,139)
♀ 0%
(0/2,137)
♂ 0%
(0/1,392)
♀ 0%
(0/1,406)
Tear-eye (mosaic) progenyb
F1 ♂ 0.1%
(3/2,828)
♀ 1.2%
(57/4,581)
F2 ♂ 0.4%
(9/2,139)
♀ 1.1%
(24/2,137)
♂ 0.1%
(2/1,392)
♀ 0.3%
(4/1,406)

aFifty hemizygous male or female AgNdoH2-TP13 were outcrossed to 50 AgNdo-H2 of the opposite sex.

bAll phenotype data displayed in the chart are pooled from 3 replicates.

♂ and ♀ symbols denote the sex of the hemizygous gene drive parent used to generate the progeny.

There were no red-eye/CFP+ progeny in the male lineages and small percentages, 0.1% to 0.4%, of the tear-eye/CFP+ phenotypes (Table 3 and Supplementary Table 11) There were a relatively small numbers of red-eye/CFP+ and tear-eye/CFP+ progeny generated from AgNdoH2-TP13 hemizygous female outcrosses when compared to the previous outcrosses with hemizygous AgTP13 females (X1 background) (Table 3 and Supplementary Table 12). There was only 1 individual in the F1 progeny exhibiting the red-eye/CFP+ phenotype (0.02%) in the AgNdoH2-TP13 hemizygous female outcross, while every AgTP13 hemizygous female (X1 background) outcross in both generations had at least 2 red-eye/CFP+ progeny, which ranged from 0.15% to 0.5% of the total (Carballar-Lejarazú et al 2023). The tear-eye progeny ranged from 0.3% to 1.2% in AgNdoH2-TP13 hemizygous female outcrosses compared to 4.2% to 13.9% in hemizygous AgTP13 female outcrosses (X1 background) (Table 3; Carballar-Lejarazú et al 2023). The observed reductions in the CFP+, tear-eye, and red-eye phenotypes in female lineages may be due to lower Cas9/gRNA activity and/or reduced susceptibility to maternal effects in the AgNdo-H2 genetic background.

Sequencing of the hemizygous drive female outcross progeny revealed that despite having low drive inheritance, the CFP− progeny had few mutant alleles (Supplementary Tables 1 and 13). Only 1 mutant allele of 206 sequenced (∼0.5%) was recovered from the F1 and F2 black-eye/CFP− progeny of female parents of the AgNdoH2-TP13 hemizygous female outcrosses. In contrast, mutant alleles were found to be much more common in the black-eye/CFP− progeny generated from male parents of AgNdoH2-TP13 hemizygous male outcrosses. Every hemizygous male outcross had some black-eye/CFP− progeny with mutant alleles present in both the F1 and F2 generations (range of 8.8% to 31.7% of total black-eye/CFP− progeny). Many of these alleles were shared among multiple progeny from the same replicate, with as many as 9/16 black-eye/CFP− progeny from one of the replicates having the same mutant allele (Supplementary Tables 1 and 14). This supports the previous observations from the introduction experiments that the AgNdo isolines may have a greater incidence of germline mutation events and resulting cluster effects. In this case, the hemizygous drive males generate a greater proportion of mutant alleles in their germline, which is in sharp contrast to previous experiments with AgTP13 (X1 background), that found drive hemizygous and homozygous females produce the majority of mutant alleles via maternal effects while germline mutation events were rare (Carballar-Lejarazú et al. 2022, 2023).

AgNdoH2-TP13 cage trials

The efficacy of the TP13 drive system in a population with the target-site SNP was assessed using triplicate, discrete, nonoverlapping cages, A, B, and C, with a founder generation (G0) release ratio of 1:1 AgNdoH2-TP13 gene-drive to AgNdo-H2 wild-type males. Three hundred randomly-selected first generation post introduction, G1, L2 larvae were put aside to start the next generation, 800 randomly selected L2 larvae were reared to pupae for sex and phenotypic screening, and the remaining larvae were counted and the numbers were added to the selected progeny to get the total population size. This was repeated to produce the subsequent G2 to G21 generations. A total of 403,044 mosquitoes, excluding the G0 founders, were scored from the 3 cages throughout the experiment (Supplementary Tables 15 to 17).

The G1 yielded a high portion of CFP+ progeny with the 69% (412/596, cage A), 80% (514/640, cage B), and 78% (471/602, cage C) being significantly higher than the expected 50% (1/2 chance of parental females mating with homozygous transgenic males) (cage A: χ2 = 87.2, P < 0.0001; cage B: χ2 = 235.2, P < 0.0001; cage C: χ2 = 192.0, P < 0.0001) (Fig. 2a). The percentage of CFP+ mosquitoes continued to increase in the caged population and reached full introduction (100% CFP+, every mosquito carrying at least 1 copy of the gene-drive system) at G3 for all 3 cages. The drive allele remained fixed in the cages until the end of the experiment at G21 without any drive-negative or unexpected phenotype mosquitoes recovered from any cage. Population sizes fluctuated between 3,000 and 11,000 mosquitoes/reproductive cycle/cage and were generally higher toward the end of the experiment (Fig. 2b).

Fig. 2.

For image description, please refer to the figure legend and surrounding text.

Population drive dynamic of AgNdoH2-TP13 in discrete nonoverlapping small cage trials. Seventy-five homozygous male AgNdoH2-TP13 were released into triplicate caged populations (cages A, B, and C) carrying 75 AgNdo-H2 males (1:1 ratio) along with 150 WT females. a) The dominant CFP marker gene was tracked every generation for gene-drive dynamics. b) Total population size of each cage at each generation.

Molecular assessments carried out to ensure drive system integrity during the cage trials showed no mutations at the gRNA target site following sequencing of the few black-eye individuals remaining in the cages before the cage population reached fixation (G3 to G4) (Supplementary Tables 1 and 18) and all mosquitoes in the cages were red-eye/CFP+ at G5 (Supplementary Tables 15–17). Assessment of CFP+/cd− mosquitoes at ∼1 yr (G18) after drive release continued to validate the insertion of the drive cassette, and amplification of the drive junction between the drive cassette and the cardinal gene homology arm showed proper drive integration into the genome (Supplementary Fig. 2, a and b). Effector scFv gene sequences and expression were assessed to ensure the activity of the effector genes. Amplification with primers spanning the promoters, 5′-UTR and 3′-UTR control DNA of the Cp and Vg DNA captured the whole sequences of the respective m1C3 and m2A10 effectors and no mutations were detected in the DNA sequences (Supplementary Fig. 2, c and d). RT-PCR result showed expression of m1C3 and m2A10 in caged CFP+/cd− mosquitoes at 24 h post blood meal as expected (Isaacs et al. 2011, 2012; Supplementary Fig. 2e).

A random selection of AgNdoH2-TP13 homozygous males was removed from each cage replicate 1 yr after drive release (G18), and outcrossed to AgNdo-H2 colony females to generate AgNdoH2-TP13 hemizygous individuals, representative of each cage, for male and female lineage gene-drive dynamic assessments. The subsequent gene drive inheritance patterns and drive associated phenotypes/genotypes observed at the 1-yr cage trial assessment then were compared to those observed at the initial assessment of the drive system (Supplementary Tables 11, 12, 19, and 20). No substantial differences were observed in gene-drive inheritance in the F1 and F2 between the initial assessment and 1 yr after cage trial initiation with hemizygous females transmitting the drive to an average of 80.7% of progeny in the initial assessment and 80.4% of progeny 1 yr later (t = −0.1, P-value = 0.92) and hemizygous males transmitted the drive to an average of 97.2% of progeny in the initial assessment and 98.2% of progeny at the 1-yr mark (t = 1.6, P-value = 0.13). The proportions of parental effect-generated phenotypes, tear-eyes and red-eyes (cardinal mutant phenotype), were low in both assessments with tear eyes being observed in less than 2% of progeny irrespective of parental lineage and cardinal red eyes only being observed in 1 or 2 rare events of a female lineage cross.

Molecular analyses of selected phenotypes from the 1-yr drive assessments showed similar results with the initial AgNdoH2-TP13 founder experiments (Supplementary Tables 1, 21, and 22). There was only 1 mutant allele recovered from the red-eye/CFP+ progeny of hemizygous female outcross; no other mutant alleles were recovered from 360 progeny sequenced (both black-eye/CFP− or black-eye/CFP+) of hemizygous AgNdoH2-TP13 female outcrosses and the black-eye/CFP+ of hemizygous AgNdoH2-TP13 male outcrosses. Mutant alleles were found in the black-eye/CFP− progeny of all hemizygous male outcrosses in both F1 and F2 1-yr assessment generations ranging from 17.4% to 17.9% (83 sequenced). This percentage range is similar to the range in the initial founder experiment, indicating that the drive system and Cas9/gRNA cleavage activity remain unchanged during the cage trial.

AgNdoH2-TP13 fitness parameters

The original AgTP13 line in the X1 genetic background had a genetic load in homozygous males that resulted in significant differences in their likelihood to contribute to the next generation when in direct 1:1 competition with wild-type males and displayed a shorter lifespan as well (Carballar-Lejarazú et al. 2023). However, no fitness load was observed in the same study with AcTP13 homozygous males after introduction into the An. coluzzii genetic background. The impact of the Ndokayo genetic background on genetic load and fitness was assessed using the same life-stage parameters measured for the AgTP13 and AcTP13 lines (Supplementary Table 23). The lines examined included AgNdo-H2, hemi- and homozygous AgNdoH2-TP13 and the AgNdo line, the latter of which has been maintained as a free-mating colony in our insectary since receipt from MR4 in 2020. The AgNdo line was used to distinguish differences in AgNdo-H2 fitness parameters that might be conflated with reductions in fitness known to occur in highly in-bred mosquito strains (Baeshen et al. 2014).

The AgNdoH2-TP13 homozygous line had slight advantages over the AgNdo-H2 line at the immature stages. Homozygous AgNdoH2-TP13 had greater larval viability (78%) and larvae developed into adults slightly faster (9 d) than AgNdo-H2 with a 59% viability and 9.4 d average development time to adulthood (Supplementary Table 23). Both hemizygous and homozygous AgNdoH2-TP13 progeny were female-biased (χ2 = 4.1, P = 0.04) and (χ2 = 5.8, P = 0.02), respectively, while neither AgNdo-H2 nor AgNdo showed a sex bias. Similar to the original AgTP13 observations, AgNdoH2-TP13 homozygotes had shorter lifespans (16 d for males and 17 d for females) when compared to AgNdo-H2 (19 d for males and 21 d for females) although this difference was more pronounced in female longevity (P = 0.0007) as compared to male longevity (P = 0.2) (Carballar-Lejarazú et al. 2023). Also similar to the original AgTP13 observations, AgNdoH2-TP13 homozygous females had greater fecundity at 86 eggs per single female egg batch compared to AgNdo-H2 females with 72 eggs per batch (P = 0.003) and their fertility was lower with a hatch rate of 67% compared to AgNdo-H2 at 75%, although the difference is not statistically significant (P-values >0.05).

AgNdoH2-TP13 progeny males from both outcrosses and intercrosses were able to outcompete equal numbers of AgNdo-H2 males and contribute ∼68% and ∼60%, respectively, of the progeny to the next generation (P-values < 0.0001; Supplementary Table 23). Assuming an equal reproductive contribution of males from the AgNdo-H2 line and AgNdo strain, progeny from a competitive cross are expected to have 14 of 16, 87.5%, of the possible haplotype 2 alleles. This expected frequency is based on a 50% frequency of both canonical wild-type and haplotype 2 alleles in samples of the AgNdo strain sequenced at the time of the experiment and a 100% frequency of haplotype 2 alleles contributed by the homozygous AgNdo-H2 males and females (Supplementary Table 1). The observed 79.3% frequency of haplotype 2 alleles in the progeny indicates that AgNdo-H2 males did not compete equally with AgNdo males in contributing to the next generation (P-values < 0.0001; Supplementary Table 23). These results, along with those of the AgNdoH2-TP13 competitive crosses, may result from poorer male reproductive health in the highly selected AgNdo-H2 colony.

AgNdoH2-TP13 parasite challenge assays

Parasite challenge assays were conducted by feeding infectious, P. falciparum (NF54 strain) gametocyte-containing blood meals to hemizygous and homozygous AgNdoH2-TP13 and AgTP13 adult females with AgNdo-WT and AgX1 as respective controls. The protocol was adapted from previous work and provides 2 additional, noninfectious blood meals at intervals after the initial infection (Carballar-Lejarazú et al. 2023, 2026a). Midguts from bloodfed females were dissected at 7 to 8 d post-infection (dpi) to determine oocyst infection prevalence and median and mean intensities of infection, and salivary glands of another cohort from the same feeding were dissected 14 to 16 dpi to obtain the same information for sporozoites.

Hemi- and homozygous AgNdoH2-TP13 mosquitoes challenged with low (0.08%) gametocytemias (percentage of gametes in infected blood preparations) showed significant reductions in oocyst prevalence, 30.6% and 56.1%, respectively, and mean intensities of infection, 33.3% and 75%, respectively (P-values ranging from 0.009 to <0.0001) (Fig. 3, Tables 4 and Supplementary 24). Median oocyst counts were reduced by half and to zero in the hemi- and homozygotes, respectively. Similar significant reductions of 44.6% and 54.4% in prevalence, and 61.1% and 66.6% in mean intensities, were seen in the AgTP13 mosquitoes challenged at the same time compared to controls (P-values from 0.0017 to <0.0001).

Fig. 3.

For image description, please refer to the figure legend and surrounding text.

Parasite challenge experiments with adult female AgNdoH2-TP13 mosquitoes and controls. Hemi- (HE) and homozygous (HO) AgTP13 and AgNdoH2-TP13 (abbreviated to AgNdo-TP13) adult females and corresponding controls (AgX1 and AgNdo-WT) were fed infectious blood meals with low (0.08%), medium (0.1%), and high (0.3%) gametocytemias. Midguts (midgut) and salivary glands (SGs) were dissected to determine oocyst and sporozoite numbers (intensities of infection), respectively. Each dot represents the parasite load in an individual tissue sample, and the horizontal bars indicate the medians. Statistically significant differences were assessed using 2-tailed Mann–Whitney U tests. Exact P-values are shown in the figure along with significance annotations (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).

Table 4.

Summary of low and medium gametocytemia parasite challenge assay results.

OOCYSTS
AgX1 (Ctl) AgTP13-HE Red AgTP13-HO Red AgNdo-WT (Ctl) AgNdoH2-TP13-HE Red AgNdoH2-TP13-HO Red
Gametocytemia Low (0.08%)
n 56 45 58 41 80 33
Prevalence 64.3% 35.6% 44.6% 29.3% 54.4% 82.9% 57.5% 30.6 36.4% 56.1
Fisher’s exact Ctl ***0.0001 **** < 0.0001 Ctl **** < 0.0001 **** < 0.0001
mean 1.8 0.7 61.1% 0.6 66.6% 2.4 1.6 33.3 0.6 75
Mann–Whitney Ctl **0.0017 **** < 0.0001 Ctl **0.0090 **** < 0.0001
median 1 0 0 2 1 50 0
range 0 to 9 0 to 4 0 to 5 0 to 8 0 to 8 0 to 4
Gametocytemia Medium (0.1%)
n 99 104 65 88 100 89
Prevalence 81.8% 85.6% +4.6 64.6% 21 94.3% 90.0% 4.6 84.3% 10.6
Fisher’s exact Ctl 0.5634 **0.0100 Ctl 0.4353 *0.0400
mean 11.9 9.7 18.5 5.1 57.1 19.0 12.8 32.6 11.2 41
Mann–Whitney Ctl 0.2508 **** < 0.0001 Ctl ***0.0007 **** < 0.0001
median 9 7.5 16.6 2 77.7 18.5 11 40.5 10 45.9
range 0 to 74 0 to 66 0 to 44 0 to 78 0 to 44 0 to 43
SPOROZOITES
AgX1 (Ctl) AgTP13-HE Red AgTP13-HO Red AgNdo-WT (Ctl) AgNdoH2-TP13-HE Red AgNdoH2-TP13-HO Red
Gametocytemia Pooled low/medium
n 29 30 37 26 28 38
Prevalence 75.9% 50.0% 34.1 40.5% 46.6 84.6% 64.3% 23.4 47.4% 43.9
Fisher’s exact Ctl ***0.0002 **** < 0.0001 Ctl **0.0011 **** < 0.0001
mean 9,455.2 27,23.0 71.2 1,131.1 88 11,803.8 5,453.6 53.8 3,844.7 67.4
Mann–Whitney Ctl *0.0239 ***0.0002 Ctl 0.063 ***0.0008
median 2700 450 83.3 0 5,400 2,250 58.3 0
range 0 to 117,000 0 to 14,400 0 to 7,200 0 to 81,000 0 to 36,000 0 to 32,400

Gametocytemia, % of red blood cells with gametocytes; n, number of mosquito samples assayed; Prevalence, percentage of samples infected; Fisher's, Fisher's exact test of significance of prevalence; Mean, average number of parasites in all mosquitoes; Median, median number of parasites in all mosquitoes; Mann–Whitney, 2-tailed Mann–Whitney U test (P-values compare distributions between groups); Range, range of parasites in all samples from low to high; Red, percent decrease in the gene-drive mosquitoes compared to the wild-type controls. Ag, Anopheles gambiae; Ctl, control; HE, hemizygous; HO, homozygous; AgNdo, Anopheles gambiae Ndokayo. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Not surprisingly, hemi- and homozygous females challenged with a medium level (0.1%) gametocytemia were not as robust in suppressing oocysts (Fig. 3, Table 4, and Supplementary Table 24). Hemizygous AgNdoH2-TP13 and AgTP13 mosquitoes showed no significant reductions in prevalence (P = 0.4353 and 0.5634, respectively), however, homozygotes were significant with reductions of 10.6% and 21% (P-values from 0.01 to 0.040). Significant reductions of mean intensities were observed in hemi- (32.6%, P = 0.0007) and homozygous (41%, P = <0.0001) AgNdoH2-TP13 and in AgTP13 homozygotes (57.1%, P = <0.0001).

The numbers of mosquitoes sampled for sporozoites in the low and medium gametocytemia regimens were low, so the results were pooled for analysis (Fig. 3, Table 4, and Supplementary Table 24). Despite this, significant reductions in prevalence were seen in hemi- (23.4%; P = 0.0011) and homozygous (43.9%; P < 0.0001) AgNdoH2-TP13 samples. Similar prevalence reductions were seen in AgTP13 samples (hemizygotes: 34.1% reduction, P = 0.0002; homozygotes: 46.6% reduction, P < 0.0001). Reductions in the mean intensities of sporozoite infection also were seen with those in AgNdoH2-TP13 homozygotes (67.4%; P = 0.0008) and AgTP13 hemi- (71.2%; P = 0.0239) and homozygotes (88%; P = 0.0002) being statistically significant. A proposed benchmark to impact parasite transmission is the proportion of mosquitoes with >10,000 sporozoites in their salivary glands (Aleshnick et al. 2020; Graumans et al. 2020). Relatively few mosquitoes exceeded this threshold in the pooled low/medium gametocytemia samples with 5/28, 5/38, 4/30, and 0/37 in AgNdoH2-TP13 hemi-, AgNdoH2-TP13 homo-, AgTP13 hemi-, and AgTP13 homozygotes, respectively (Table 4 and Supplementary Table 24).

With 1 exception, similar challenges of all lines using a high (0.3%) gametocytemia showed lowered or no statistically significant reductions in oocyst prevalence (AgNdoH2-TP13 hemizygotes, 0.5%, P > 0.999; AgNdoH2-TP13 homozygotes, 5.9%, P = 0.0649; AgTP13 homozygotes, 2.4%, P = 0.6827) and sporozoite (AgNdoH2-TP13 hemizygotes, 4.2%, P = 0.3727; AgNdoH2-TP13 homozygotes, 12.5%, P = 0.0081; AgTP13 hemizygotes 23.5, P = 0.0002; AgTP13 homozygotes, 21.9%, P = 0.0004) (Fig. 3, Table 5, and Supplementary Table 24). AgTP13 hemizygotes showed a slight increase of 4.25 (P > 0.999). Oocyst and sporozoite mean intensities reflected the higher gametocytemia loads with significant reductions seen in oocyst (AgNdoH2-TP13 hemi, 29.2%, P = 0.0002; AgNdoH2-TP13 homozygotes, 55.6%, P < 0.0001; AgTP13 hemizygotes 3.1%; P = 0.6747; AgTP13 homozygotes, 11%, P = 0.1058) and sporozoite (AgNdoH2-TP13 hemizygotes, 44.5%, P = 0.0132%; AgNdoH2-TP13 homozygotes, 86.7%, P = <0.0001; AgTP13 hemizygotes 42.5%, P = 0.0193; AgTP13 homozygotes, 73.6.0%, P = <0.0001). More samples had >10,000 sporozoites in their salivary glands (AgNdoH2-TP13 hemizygotes, 21/25; AgNdoH2-TP13, 21/25; AgTP13 hemizygotes, 24/34, and AgTP13 homozygotes, 13/25; Table 5 and Supplementary Table 24). These combined data show that the effector molecules suppress parasite oocysts and sporozoites in the AgNdoH2-TP13 lines with expected impacts greater in homozygotes than hemizygotes (Carballar-Lejarazú et al. 2023, 2026a). Furthermore, the impact is generally numerically higher in the AgNdoH2-TP13 females than in the corresponding AgTP13 mosquitoes tested at the same time.

Table 5.

Summary of high gametocytemia parasite challenge assay results.

OOCYSTS
AgX1 (Ctl) AgTP13-HE Red AgTP13-HO Red AgNdo-WT (Ctl) AgNdoH2-TP13-HE Red AgNdoH2-TP13-HO Red
Gametocytemia High (0.3%)
n 64 85 75 106 72 59
Prevalence 98.4% 98.8% +4.2 96.0% 2.4 99.1% 98.6% 0.5 93.2% 5.9
Fisher’s exact Ctl >0.9999 0.6827 Ctl >0.9999 0.0649
mean 34.5 33.4 3.1 30.7 11 41.7 29.5 29.2 18.5 55.6
Mann–Whitney Ctl 0.6747 0.1058 Ctl ***0.0002 **** < 0.0001
median 34 32 5.8 27 20.5 38.5 27.5 28.6 19 50.6
range 0 to 76 0 to 85 0 to 91 0 to 95 0 to 80 0 to 48
SPOROZOITES
AgX1 (Ctl) AgTP13-HE Red AgTP13-HO Red AgNdo-WT (Ctl) AgNdoH2-TP13-HE Red AgNdoH2-TP13-HO Red
n 26 34 25 25 25 25
Prevalence 92.3% 70.6% 23.5 72.0% 21.9 96.0% 92.0% 4.2 84.0% 12.5
Fisher’s exact Ctl ***0.0002 ***0.0004 Ctl 0.3727 **0.0081
mean 49,673.1 28,535.3 42.5 13,104.0 73.6 43,200.0 23,544.0 45.5 5,750.4 86.7
Mann–Whitney Ctl *0.0193 **** < 0.0001 Ctl *0.0132 **** < 0.0001
median 34,650 25,200 27.2 12,600 67.6 45,000 21,600 52 4,500 90
range 0 to 119,700 0 to 100,800 0 to 37,800 0 to 100,800 0 to 54,000 0 to 24,000

Gametocytemia, % of red blood cells with gametocytes; n, number of mosquito samples assayed; Prevalence, percentage of samples infected; Fisher's, Fisher's exact test of significance of prevalence; Mean, average number of parasites in all mosquitoes; Median, median number of parasites in all mosquitoes; Mann–Whitney, 2-tailed Mann–Whitney U test (P-values compare distributions between groups); Range, range of parasites in all samples from low to high; Red, percent decrease in the gene-drive mosquitoes compared to the wild-type controls. Ag, Anopheles gambiae; Ctl, control; HE, hemizygous; HO, homozygous; AgNdo, Anopheles gambiae Ndokayo. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

Discussion

Gene drive-based approaches for population modification of malaria vector mosquitoes are being developed to suppress transmission of parasites and reduce human morbidity and mortality (Carballar-Lejarazú and James 2017). These systems are being evaluated in a phased approach that emphasizes extensive laboratory characterization before advancing to field trials (World Health Organization 2021). The most advanced systems are based on CRISPR biology and utilize a Cas9 endonuclease and small gRNA to cleave a specific genomic target site and initiate HDR mechanisms to propagate the system (Carballar-Lejarazú and James 2017). A key property for their success will be their ability to initiate HDR in genomes that have sequence variations at the target site. These variants can result from alternative DNA repair outcomes, for example, nonhomologous end-joining (NHEJ), microhomologous end-joining (MMEJ), or single-strand annealing (SSA) following Cas9/gRNA cleavage, or may be preexisting DNA sequence polymorphisms in mosquito populations. We looked previously at the frequency and outcome of the system-generated variants for the TP13 gene-drive system and investigated here the impact of naturally-occurring target-site variants on the drive dynamics of the same system (Carballar-Lejarazú et al. 2025).

A survey of wild and colonized An. gambiae s.l. genomes revealed that the most abundant SNP is located within the gRNA target site at position 2R:38748898, 17 bp to the 3′-end of the PAM site, and is present in as many as 43% of the TP13 target sites in geographically diverse strains (Fig. 1; Ag1000G Consortium 2023). The Ndokayo strain from Cameroon has 29.2% of its target sites with this SNP present in 2 distinct haplotypes, H-1 and H-2, that had 1 or 3 additional SNPs within a 15- to 17-bp region outside the target-site sequence. Careful single mosquito breeding and molecular monitoring resulted in the generation of the 3 distinct lines, AgNdo-WT, AgNdo-H1, and AgNdo-H2, homozygous for the canonical wild-type or haplotype sequences. No recombinant haplotypes were observed in subsequent sequence analyses, but the tight linkage of the SNPs would have required many more samples than were evaluated here to detect them.

Previous work with the core gene drive system, AgNosCd-1, found that 12 of the 23 positions in the target site of multiple and diverse specimens of An. gambiae and An. coluzzii had SNPs (Carballar-Lejarazú et al. 2020). All but 1 of the 12 were present in low allele frequencies (<5.8%) with 5 SNPs in nucleotide positions in the PAM site (positions 1 and 2) and seed region (positions 4 to 8) predicted to impact Cas9/gRNA cleavage (Drury et al. 2017). Four sites, including the 2R:38748898 SNP, selected based on their frequency (>1%) and 1 for being in the predicted high-impact PAM region, were assayed in vitro for Cas9/gRNA-mediated cleavage (Carballar-Lejarazú et al. 2020). All sites were cleaved although the PAM site variant appeared qualitatively to be cleaved less efficiently. The in vitro cleavage analysis of the 2R:38748898 SNP was extended here to evaluate it in the context of the additional SNPs represented in the Ndokayo haplotypes and all were cleaved efficiently. We interpret these findings to indicate that the additional SNPs did not have an impact on Cas9/gRNA recognition and subsequent cleavage of the H-1 and H-2 haplotypes. Similar conclusions were derived from in vitro analysis of a rare natural SNP variant in the gRNA target site of the female-specific exon of the An. gambiae double-sex (Agdsx) gene (Kyrou et al. 2018).

Efficient drive dynamics depend both on the initial cleavage of the target site as well as the subsequent DNA repair process that leads to HDR. The in vitro assays validated the initial cleavage results, and subsequent HDR was shown by outcrossing the AgTP13 line to the homozygous AgNdo-H1, AgNdo-H2 and AgNdo-WT control lines to generate mosquitoes hemizygous for the drive system and one of the haplotypes. Subsequent genotype-specific intercrosses validated high gene-drive inheritance and gene-drive conversion rates comparable to previous efficiencies seen with other TP13 drive system analyses (Carballar-Lejarazú et al. 2023, 2025; Tushar et al. 2024). Furthermore, the high conversion rates (∼85%) of all lines validate the in vitro cleavage assay. These combined data support the conclusion that the TP13 gene-drive system functions at a high level for both target-site cleavage and HDR in lines carrying SNPs in and adjacent to the target site.

Our work is consistent with that of others who have shown that SNPs surrounding the target site may not have an impact on Cas9/gRNA recognition and cleavage in An. gambiae s.l. (Pescod et al. 2023). However, small mismatches in homology (1.2% sequence variation between donor template and invading strand) have been shown to impact integration and HDR in Ae. aegypti (Ang et al. 2022). Profound effects of surrounding DNA diversity on successful drive HDR were reported recently in Cu. quinquefasciatus (Harvey-Samuel et al. 2026). While this type of drive resistance that biases the post-cleavage repair outcome away from HDR has not been investigated in detail yet in Anopheles species, the relatively compact genomes and genomic organization of repetitive DNA of the anophelines compared to the culicines may account for the differences in HDR efficiency observed between the 2 subfamilies (Arensburger et al. 2010; Matthews et al. 2018).

Experiments with the AgNdoH2-TP13 line validate that the TP13 gene-drive system functions as effectively in a variant Ndokayo genetic background as it does in other Anopheles strains. However, notable differences include the observation that hemizygous AgNdo isoline drive males generate greater proportions of germline mutant alleles compared to those seen previously with AgTP13 (X1 background) where drive hemi- and homozygous females produced the majority of mutant alleles via maternal effects on pre-blastoderm nuclei while germline mutation events were rare (Carballar-Lejarazú et al. 2022, 2023, 2025). Proposed reasons for these differences are speculative at best, but they may reflect differential, strain-specific Cas9/gRNA complex stability in the gonial cells (spermatogonia, oogonia) versus the gametes (sperm and eggs), and the resulting effects of inherited complexes in embryos originating from drive-carrying females (the observed maternal effects) on the large number of potential pre-blastoderm target nuclei compared with embryos originating from drive-carrying males (paternal effects) (Carballar-Lejarazú et al. 2025).

Mating competition experiments with wild-type males and cage trials showed that AgNdoH2-TP13 males outperformed the AgNdoH2 males, and these results are consistent with previous observations that outcrossing TP13 into a different genetic background, an. coluzzii MOPTI strain, also improved male performance (Carballar-Lejarazú et al. 2023). Cage trials showed excellent gene drive dynamics with full AgNdoH2-TP13 introduction (every mosquito containing 1 copy of the drive system) by the third to fourth generation and apparent homozygosity as early as the fifth generation following release. Molecular assessments of sampled mosquitoes showed no mutations of any type in the gRNA target site consistent with negligible or no drive system-generated mutant alleles. The 1-yr assessment (18 generations after drive release) of samples validated the long-term stability of the drive cassette in the genome consistent with what was seen with TP13 performance in different genetic backgrounds (Carballar-Lejarazú et al. 2023, 2026b).

Previous fitness experiments evaluating possible genetic loads imposed by TP13 had shown no consistent impacts associated with the integration and expression of the gene-drive system (Carballar-Lejarazú et al. 2023). Most suboptimal performance measurements resulted from issues with the specific strain into which TP13 was integrated with some genetic backgrounds being less fit than others. However, recent retrospective comparisons of males competitiveness across a number of lines showed that hemizygous males contributed more to the next generation than homozygotes when in direct competition with wild-type males (Carballar-Lejarazú et al. 2023, 2026a, 2026b). Remarkably, 2 previously evaluated Tp13 lines in the An. coluzzii MOPTI genetic background either outcompete or are as competitive as their respective wild-types regardless of their gene-drive copy number and only those in the An. gambiae X1 background being less competitive. The results here are consistent with these findings and also indicate a potential load associated with the colonization of the Ndokayo strain, a phenomenon noted previously for strains maintained in long-term culture (Baeshen et al. 2014). The observed improvements in AgNdoH2-TP13 female fertility and fecundity compared with the other lines are expected to be the result of outcrossing (“heterosis”) of the AgTP13 to the AgNdo-H2 line as was seen with outcrosses of other long-term colonies (Ekechukwu et al. 2015).

Parasite challenge assays validate the function of the effector genes in the Ndokayo genetic background. While threshold values adopted previously by us as benchmarks (eg ≥32% reduction in oocyst prevalence over 3 transmission cycles and salivary gland sporozoite loads <10,000) have not been validated in field transmission studies, they do provide early-phase practical targets for evaluating effector performance (Blagborough et al. 2013; Aleshnick et al. 2020; Carballar-Lejarazú et al. 2020, 2023, 2025, 2026a, 2026b; Graumans et al. 2020). As observed previously, gametocytemia percentages impact infection outcomes with low and medium-low challenge outcomes meeting most threshold value levels. Reductions under low-gametocytemia conditions are informative because these conditions reflect many natural transmission settings where infected human hosts often carry low gametocyte densities (Churcher et al. 2013; Gonçalves et al. 2017). Notably homozygous mosquitoes with 2 copies of the effector gene cassette provide greater reductions than hemizygotes with 1 copy demonstrating a clear gene dosage effect likely contributing to increased levels of the effector proteins. The significantly lower parasite suppression observed for hemizygous female is not expected to have any epidemiologically significant impact since hemizygous females are only present during the initial introgression phase, but the rapid accumulation of drive alleles within the population ensures they become exceedingly rare as the genetic modification stabilizes into homozygosity. Mosquitoes challenged with high percentage gametocytemias generally did not meet the threshold values although some did show statistically significant reductions in prevalence and intensities of infection with homozygotes performing particularly well.

The work done here and that of others support the conclusion that a negative impact of gRNA target-site polymorphisms on gene drive dynamics in anophelines is far likelier to arise from gene drive system-generated resistance mutations than from naturally occurring variants. This is due largely to careful selection of gRNA target sites for those with minimal natural variation. We looked previously at the frequency and outcome of the system-generated variants for the TP13 gene-drive system and found that functional and nonfunctional mutant alleles were generated in germlines at average rates per target gene/generation higher than most naturally occurring gRNA target-site polymorphisms and that clustering effects could amplify inheritance frequencies of some of the mutant alleles (Carballar-Lejarazú et al. 2025). Some mutations, most notably the deletions, produce target sites that are resistant to Cas9/gRNA complex cleavage, and these can have an impact on gene-drive dynamics in small-scale cage trials (Carballar-Lejarazú et al. 2023, 2025, 2026b). Recently, work done in vivo with the previously noted, naturally occurring SNP in the Agdsx gene showed that it was susceptible to Cas9/gRNA cleavage and allowed gene drive (Kyrou et al. 2018; Morianou et al. 2026). However, the latter group was able to generate mutations that conferred variable levels of resistance as a result of alternate pathways of post-cleavage DNA repair. Thus, the focus of the impact of target-site variations on gene-drive sustainability will be on mitigating heritable system-generated resistance alleles (eg Champer et al. 2020).

Previous and ongoing work show that gene-drive lines carrying the TP13 system meet acceptable TPP requirements as part of Phase 1 evaluations prior to transitioning to possible field trials (Carballar-Lejarazú and James 2017). They have high drive conversion and inheritance rates, parasite suppression levels modeled to confer epidemiological impacts, no fitness loads that impact gene-drive dynamics in all but 1 line evaluated and long-term stability of both drive and parasite suppression components in multiple lines of the An. gambaie species complex (Carballar-Lejarazú et al. 2023, 2025, 2026a, 2026b; Tushar et al. 2024). The ability of these lines to exhibit robust drive in the presence of existing target-site variants shown here adds to the list of important features that will be crucial for their success in the Phase 2 testing in field mosquito populations.

Supplementary Material

iyag221_Supplementary_Data

Acknowledgments

We thank Drusilla Stillinger, Devin Nguyen, Lorena Winokur, and Tanaya Sheth for mosquito husbandry; Rhodell Valdez for help in preparing the manuscript; and the Johns Hopkins Malaria Research Institute Insectary and Parasite Core Facility and the Bloomberg Philanthropies for the parasite challenge work.

Contributor Information

Rebeca Carballar-Lejarazú, Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, CA 92697-4025, United States.

Brian McNeely, Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, CA 92697-4025, United States.

Yuemei Dong, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, MD 21205, United States.

Thai Binh Pham, Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, CA 92697-4025, United States.

Taylor Tushar, Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, CA 92697-4025, United States.

Isaac Owusu-Frimpong, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, MD 21205, United States.

George Dimopoulos, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Malaria Research Institute, Johns Hopkins University, Baltimore, MD 21205, United States.

Anthony A James, Department of Microbiology & Molecular Genetics, University of California, Irvine, Irvine, CA 92697-4025, United States; Department of Molecular Biology & Biochemistry, University of California, Irvine, Irvine, CA 92697-3900, United States.

Data availability

All referenced data are available in the manuscript and Supplementary Materials.

Supplemental material available at GENETICS online.

Funding

Support was provided by the University of California Irvine Malaria Initiative, the National Institute of Allergy and Infectious Diseases (NIAID R01 AI170692), the Bill & Melinda Gates Foundation (INV-043645), and the Bloomberg Philanthropies. A.A.J. is a Donald Bren Professor at the University of California, Irvine.

Literature cited

  1. Ag1000G Consortium . 2023. Anopheles gambiae genomic surveillance project, Ag3.8 Anopheles gambiae data resource. MalariaGEN. https://www.malariagen.net/data_package/ag38-anopheles-gambiae-data-resource/. [Google Scholar]
  2. Aleshnick  M  et al.  2020. Experimental determination of the force of malaria infection reveals a nonlinear relationship to mosquito sporozoite loads. PLoS Pathog. 16:e1008181. 10.1371/journal.ppat.1008181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ang  JX  et al.  2022. Considerations for homology-based DNA repair in mosquitoes: impact of sequence heterology and donor template source. PLoS Genet. 18:e1010060. 10.1371/journal.pgen.1010060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anopheles gambiae 1000 Genomes Consortium . 2017. Genetic diversity of the African malaria vector Anopheles gambiae. Nature. 552:96–100. 10.1038/nature24995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arensburger  P  et al.  2010. Sequencing of Culex quinquefasciatus establishes a platform for mosquito comparative genomics. Science. 330:86–88. 10.1126/science.1191864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baeshen  R  et al.  2014. Differential effects of inbreeding and selection on male reproductive phenotype associated with the colonization and laboratory maintenance of Anopheles gambiae. Malar J. 13:19. 10.1186/1475-2875-13-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BEI Resources . 2024. BEI Resources Repository [Internet]. Manassas (VA): BEI Resources; [cited 2024 Apr 26]. https://www.beiresources.org/catalog.
  8. Blagborough  AM  et al.  2013. Transmission-blocking interventions eliminate malaria from laboratory populations. Nat Commun. 4:1812. 10.1038/ncomms2840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carballar-Lejarazú  R  et al.  2020. Next-generation gene drive for population modification of the malaria vector mosquito, Anopheles gambiae. Proc Natl Acad Sci USA. 117:22805–22814. 10.1073/pnas.2010214117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Carballar-Lejarazú  R  et al.  2022. Cas9-mediated maternal-effect and derived resistance alleles in a gene-drive strain of the African malaria vector mosquito, Anopheles gambiae. GENETICS. 221:iyac055. 10.1093/genetics/iyac055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carballar-Lejarazú  R  et al.  2023. Dual effector population modification gene-drive strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzzii. Proc Natl Acad Sci USA. 120:e2221118120. 10.1073/pnas.2221118120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carballar-Lejarazú  R  et al.  2025. Mutant allele formation and inheritance during Cas9/guide RNA-mediated gene drive in a population modification mosquito strain for human malaria control. GENETICS. 231:iyaf176. 10.1093/genetics/iyaf176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Carballar-Lejarazú  R  et al.  2026a. Compound effector genes suppress malaria parasite infections in gene-drive population modification strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzzii. G3 (Bethesda). 16:jkag014. 10.1093/g3journal/jkag014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Carballar-Lejarazú  R  et al.  2026b. Long-term stability and performance of Cas9/guide RNA-based gene drives in anopheline mosquitoes. Proc Natl Acad Sci USA. 123:e2605739123. 10.1073/pnas.2605739123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Carballar-Lejarazú  R, James  AA. 2017. Population modification of anopheline species to control malaria transmission. Pathog Glob Health. 111:424–435. 10.1080/20477724.2018.1427192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Champer  SE  et al.  2020. Computational and experimental performance of CRISPR homing gene drive strategies with multiplexed gRNAs. Sci Adv. 6:eaaz0525. 10.1126/sciadv.aaz0525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Churcher  TS  et al.  2013. Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. eLife. 2:e00626. 10.7554/eLife.00626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Clement  K  et al.  2019. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol. 37:224–226. 10.1038/s41587-019-0032-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Drury  DW  et al.  2017. CRISPR/cas9 gene drives in genetically variable and nonrandomly mating wild populations. Sci Adv. 3:e1601910. 10.1126/sciadv.1601910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ekechukwu  NE  et al.  2015. Heterosis increases fertility, fecundity, and survival of laboratory-produced F1 hybrid males of the malaria mosquito Anopheles coluzzii. G3 (Bethesda). 5:2693–2709. 10.1534/g3.115.021436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fu  R  et al.  2022. Systematic decomposition of sequence determinants governing CRISPR/cas9 specificity. Nat Commun. 13:474. 10.1038/s41467-022-28028-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gantz  VM  et al.  2015. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci USA. 112:E6736–E6743. 10.1073/pnas.1521077112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gonçalves  BP  et al.  2017. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun. 8:1133. 10.1038/s41467-017-01270-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Graumans  W  et al.  2020. When is a plasmodium-infected mosquito an infectious mosquito?  Trends Parasitol. 36:705–716. 10.1016/j.pt.2020.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harvey-Samuel  T  et al.  2026. Sequence mismatch between gene-drive and target-site flanking regions significantly impairs homing efficiency in Culex quinquefasciatus. GENETICS. 232:iyag013. 10.1093/genetics/iyag013. [DOI] [PubMed] [Google Scholar]
  26. Hsu  PD  et al.  2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 31:827–832. 10.1038/nbt.2647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Isaacs  AT  et al.  2011. Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi. PLoS Pathog. 7:e1002017. 10.1371/journal.ppat.1002017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Isaacs  AT  et al.  2012. Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development. Proc Natl Acad Sci USA. 109:E1922–E1930. 10.1073/pnas.1207738109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kim  HK  et al.  2020. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells. Nat Biomed Eng. 4:111–124. 10.1038/s41551-019-0505-1. [DOI] [PubMed] [Google Scholar]
  30. Kyrou  K  et al.  2018. A CRISPR–cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat Biotechnol. 36:1062–1066. 10.1038/nbt.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lack  JB  et al.  2016. A thousand fly genomes: an expanded Drosophila genome nexus. Mol Biol Evol. 33:3308–3313. 10.1093/molbev/msw195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Matthews  BJ  et al.  2018. Improved reference genome of Aedes aegypti informs arbovirus vector control. Nature. 563:501–507. 10.1038/s41586-018-0692-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morianou  I  et al.  2026. Engineering resilient gene drives for sustainable malaria control by predicting, testing and overcoming target site resistance in Anopheles gambiae. PLoS Biol. 24:e3003879. 10.1371/journal.pbio.3003879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. National Geographic Society . 2025. MapMaker. https://www.nationalgeographic.org/society/learn/mapmaker-launch-guide/.
  35. Pescod  P  et al.  2023. Measuring the impact of genetic heterogeneity and chromosomal inversions on the efficacy of CRISPR-cas9 gene drives in different strains of Anopheles gambiae. CRISPR J. 6:419–429. 10.1089/crispr.2023.0030. [DOI] [PubMed] [Google Scholar]
  36. Rutkauskas  M  et al.  2015. Directional R-loop formation by the CRISPR-cas surveillance complex cascade provides efficient off-target site rejection. Cell Rep. 10:1534–1543. 10.1016/j.celrep.2015.02.013. [DOI] [PubMed] [Google Scholar]
  37. Sánchez  CHM  et al.  2020. MGDrivE: a modular simulation framework for the spread of gene drives through spatially explicit mosquito populations. Methods Ecol Evol. 11:229–239. 10.1111/2041-210X.13318. [DOI] [Google Scholar]
  38. Schmidt  H  et al.  2020. Abundance of conserved CRISPR-cas9 target sites within the highly polymorphic genomes of anopheles and Aedes mosquitoes. Nat Commun. 11:1425. 10.1038/s41467-020-15204-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tripathi  AK  et al.  2020. Plasmodium falciparum gametocyte culture and mosquito infection through artificial membrane feeding. J Vis Exp. 161:e61426. 10.3791/61426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tushar  T  et al.  2024. Cas9/guide RNA-based gene-drive dynamics following introduction and introgression into diverse anopheline mosquito genetic backgrounds. BMC Genomics. 25:1078. 10.1186/s12864-024-10952-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Volohonsky  G  et al.  2015. Tools for Anopheles gambiae transgenesis. G3 (Bethesda). 5:1151–1163. 10.1534/g3.115.016808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. World Health Organization . 2021. Guidance framework for testing genetically modified mosquitoes. 2nd ed. World Health Organization. https://www.who.int/publications/i/item/9789240025233. [Google Scholar]
  43. World Health Organization . 2025. World malaria report 2025: addressing the threat of antimalarial drug resistance. World Health Organization. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025. [Google Scholar]
  44. Wu  X  et al.  2014. Target specificity of the CRISPR-Cas9 system. Quant Biol. 2:59–70. 10.1007/s40484-014-0030-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

iyag221_Supplementary_Data

Data Availability Statement

All referenced data are available in the manuscript and Supplementary Materials.

Supplemental material available at GENETICS online.


Articles from Genetics are provided here courtesy of Oxford University Press

RESOURCES